A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression

Authors:	Deborah Roth Jeffrey Mattes K. Harnett Sheehan David V. Sheehan

Affiliation:	¹ Department of Psychiatry and Behavioral Medicine, University of South Florida College of Medicine, Tampa, Florida, USA ² Psychopharmacology Research Association of Princeton,Princeton, New Jersey, USA

Abstract:	Deborah Roth, Jeffrey Mattes, K. Harnett Sheehan and David V. Sheehan: A Double-Blind Comparison of Fluvoxamine, Desipramine and Placebo in Outpatients with Depression. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 1990, : 929–939. 1. 1. The efficacy of fluvoxamine is compared to that of desipramine in a multicenter double blind placebo controlled six-week flexible dose trial of 90 outpatients with major depressive disorder. 2. 2. Although overall drug effects were relatively weak, there were trends suggesting separation of both active drugs from placebo at week six. Both drugs were well tolerated. 3. 3. Studies of major depression ought to be designed to last 8–10 weeks in order to demonstrate placebo active drug differences and the stability of such a difference should it occur in the first six weeks. Author Keywords: Depression; Desipramine; Double-Blind; Fluvoxamine

Keywords:	Depression Desipramine Double-Blind Fluvoxamine
本文献已被 ScienceDirect 等数据库收录！